SPY458.13+7.63 1.69%
DIA347.55+7.09 2.08%
IXIC15,380.15+126.10 0.83%

Virios Therapeutics Q3 EPS $(0.49) Beats $(0.69) Estimate

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.69) by 28.99 percent.

Benzinga · 11/11/2021 07:13
Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.69) by 28.99 percent.